Literature DB >> 23644307

Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis.

Ashok Verma1.   

Abstract

Amyotrophic lateral sclerosis (ALS) typically commences in a discrete location in a limb or bulbar territory muscles and then spreads to the adjacent anatomical regions. This pattern is consistent with a contiguous spread of the disease process in motor neuron network resulting in progressive motor weakness. The etiology of ALS onset and the mechanism of the regional ALS spread remain elusive. Over the past 5 years, identification of mutations in two RNA binding proteins, trans active response (TAR) DNA-binding protein (TDP-43) and fused in sarcoma (FUS), in patients with familial ALS has led to a major shift in our understanding of the ALS disease mechanism. In addition to their role in RNA metabolism, TDP-43 and FUS form protein aggregates in the affected neurons. More recent findings demonstrating that both TDP-43 and FUS contain glutamine/asparagine (Q/N) residue-rich prion-like domains have spurred intense research interest. This brief review discusses the prion-related domains in TDP-43 and FUS and their implication in protein aggregate formation and disease spread in ALS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644307     DOI: 10.4103/0028-3886.111109

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

1.  Impact of Limb Phenotype on Tongue Denervation Atrophy, Dysphagia Penetrance, and Survival Time in a Mouse Model of ALS.

Authors:  Marissa Mueller; Rebecca Thompson; Kate L Osman; Ellyn Andel; Chandler A DeJonge; Sophia Kington; Zola Stephenson; Ali Hamad; Filiz Bunyak; Nicole L Nichols; Teresa E Lever
Journal:  Dysphagia       Date:  2022-04-15       Impact factor: 2.733

2.  A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules.

Authors:  Klaus Højgaard Jensen; Anna Katharina Stalder; Rasmus Wernersson; Tim-Christoph Roloff-Handschin; Daniel Hvidberg Hansen; Peter M A Groenen
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.752

Review 3.  Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?

Authors:  Shynrye Lee; Hyung-Jun Kim
Journal:  Exp Neurobiol       Date:  2014-12-17       Impact factor: 3.261

4.  Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).

Authors:  Eleonora Dalla Bella; Irene Tramacere; Giovanni Antonini; Giuseppe Borghero; Margherita Capasso; Claudia Caponnetto; Adriano Chiò; Massimo Corbo; Roberto Eleopra; Massimiliano Filosto; Fabio Giannini; Enrico Granieri; Vincenzo La Bella; Christian Lunetta; Jessica Mandrioli; Letizia Mazzini; Sonia Messina; Maria Rosaria Monsurrò; Gabriele Mora; Nilo Riva; Romana Rizzi; Gabriele Siciliano; Vincenzo Silani; Isabella Simone; Gianni Sorarù; Paolo Volanti; Giuseppe Lauria
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

Review 5.  Prions, prion-like prionoids, and neurodegenerative disorders.

Authors:  Ashok Verma
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.